{"id":178484,"date":"2026-01-30T06:08:18","date_gmt":"2026-01-30T11:08:18","guid":{"rendered":"https:\/\/alphastreet.com\/india\/?p=178484"},"modified":"2026-01-30T06:08:18","modified_gmt":"2026-01-30T11:08:18","slug":"indegene-posts-31-revenue-jump-in-q3-crosses-100-million-quarterly-milestone","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/indegene-posts-31-revenue-jump-in-q3-crosses-100-million-quarterly-milestone\/","title":{"rendered":"Indegene posts 31% revenue jump in Q3, crosses $100 million quarterly milestone"},"content":{"rendered":"\n<p>Indegene Ltd (NSE:INDGN), a life sciences services firm reported more than 30% year-on-year revenue growth for the December quarter, crossing the $100 million quarterly revenue mark for the first time, as strong client expansion and large deal wins boosted performance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Revenue growth hits record level<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Indegene reported revenue from operations of 9,421 million rupees ($106.1 million) for the quarter ended Dec. 31, 2025, marking 30.8% year-on-year growth and 17.1% sequential growth. This was the first time the life sciences services company crossed the $100 million mark in a single quarter.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Profitability resilient despite acquisition costs<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Adjusted EBITDA rose 15.7% year-on-year to 1,747 million rupees, while the adjusted EBITDA margin improved to 18.5%, up 30 basis points from the previous quarter.<\/li>\n\n\n\n<li>Reported profit after tax was 1,026 million rupees, broadly flat sequentially and lower than a year earlier due to one-time expenses and higher non-cash amortization related to recent acquisitions. The company said these impacts are temporary and expects margins to strengthen as integration synergies are realized.<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"480\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/IND1.png\" alt=\"\" class=\"wp-image-178486\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/IND1.png 640w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/01\/IND1-300x225.png 300w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Client expansion and large deal wins<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Customer relationships deepened during the quarter, with three of the company\u2019s top five clients now generating more than $25 million in annual revenue each. Indegene also increased the number of $1 million-plus annual revenue clients to 52.<\/li>\n\n\n\n<li>The company secured multiple marquee deals, including two contracts each exceeding $10 million annual contract value across five work orders, and another exceeding $5 million annual contract value with $20 million total contract value across two work orders. These wins focus on combining execution capabilities with AI-led transformation of client operations.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Productivity gains from technology and AI<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Revenue per employee crossed $70,000 on an annualized basis, which the company described as the highest in the industry. Management attributed this to technology and AI-driven productivity improvements that allow scaling without proportional headcount growth.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Strategic acquisitions strengthen capabilities<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>During the quarter Indegene completed the acquisitions of BioPharm in the United States and Warn &amp; Co. in the United Kingdom. These additions expand the company&#8217;s omnichannel, consulting and domain expertise in life sciences commercialization and are expected to contribute to higher-value services over time.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Healthy balance sheet supports growth<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Even after acquisition-related outflows, the company reported cash and investments of 13,954 million rupees, supported by ongoing operating cash generation. Management said this financial strength provides flexibility for further capability building and expansion.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Outlook for sustained profitable growth<\/strong> <\/h2>\n\n\n\n<p>Indegene said the combination of strong deal momentum, deeper top-client relationships and integration of the new businesses positions it for continued profitable growth. Serving global biopharma companies across clinical, medical and commercial functions, the firm expects rising demand for AI-enabled and data-driven commercialization services to drive further scale and earnings expansion.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Indegene Ltd (NSE:INDGN), a life sciences services firm reported more than 30% year-on-year revenue growth for the December quarter, crossing the $100 million quarterly revenue mark for the first time, as strong client expansion and large deal wins boosted performance. Revenue growth hits record level Profitability resilient despite acquisition costs Client expansion and large deal [&hellip;]<\/p>\n","protected":false},"author":2378,"featured_media":125269,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5,1941,392,5747],"tags":[8150,9138],"class_list":["post-178484","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest","category-stock-analysis","category-earnings","category-healthcare-stocks","tag-life-sciences","tag-pharma"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":178489,"url":"https:\/\/alphastreet.com\/india\/indegene-crosses-100-million-quarterly-revenue-as-q3-growth-accelerates-on-pharma-demand-and-ai-led-services\/","url_meta":{"origin":178484,"position":0},"title":"Indegene crosses $100 million quarterly revenue as Q3 growth accelerates on pharma demand and AI-led services","author":"Staff Correspondent","date":"January 30, 2026","format":false,"excerpt":"Indegene Ltd (NSE:INDGN), a life sciences services firm, reported more than 30% year-on-year revenue growth for the December quarter, crossing the $100 million quarterly revenue mark for the first time, as strong client expansion and large deal wins boosted performance. Revenue surges in latest quarter, profitability held back by acquisition\u2026","rel":"","context":"In &quot;LATEST&quot;","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/10\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":171334,"url":"https:\/\/alphastreet.com\/india\/indegene-leading-digital-life-sciences-transformation\/","url_meta":{"origin":178484,"position":1},"title":"Indegene: Leading Digital Life Sciences Transformation","author":"Divyansh_Kasana","date":"September 22, 2025","format":false,"excerpt":"Company Overview: Indegene Ltd. positions itself as an indispensable enabler for digital-first transformation in the global life sciences arena. As a specialized partner to leading pharma and biotech clients, Indegene\u2019s suite of proprietary AI\/cloud-enabled solutions, next-generation analytics, deep clinical expertise, and end-to-end engagement platforms address critical needs in digital commercialization,\u2026","rel":"","context":"In &quot;Research Summary&quot;","block_context":{"text":"Research Summary","link":"https:\/\/alphastreet.com\/india\/category\/research-summary\/"},"img":{"alt_text":"Indegene","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":142055,"url":"https:\/\/alphastreet.com\/india\/one-97-communications-q3fy23-earnings-story\/","url_meta":{"origin":178484,"position":2},"title":"One 97 Communications Q3FY23 Earnings Story","author":"Karan_Singh","date":"February 16, 2023","format":false,"excerpt":"One 97 Communications Ltd was incorporated in 2000 and has grown to become India's leading digital ecosystem for merchants as well as consumers. As reported on the 31st of March, 2021, the company expands over a 333 million+ client base along with 21 million + registered merchants to whom it\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"Indegene","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":166243,"url":"https:\/\/alphastreet.com\/india\/indegene-ltd-q2fy25-23-rise-in-profits\/","url_meta":{"origin":178484,"position":3},"title":"Indegene Ltd Q2FY25; 23% rise in Profits","author":"Divyansh_Kasana","date":"January 7, 2025","format":false,"excerpt":"Incorporated in 1998, Indegene Ltd provides solutions consisting of analytics, technology and commercial, medical, regulatory and safety services to life science and health care organizations Financial Results: Indegene Ltd reported Revenues for Q2FY25 of \u20b9687.00 Crores up from \u20b9636.00 Crore year on year, a rise of 8.02%. Total Expenses for\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/JJ.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":181534,"url":"https:\/\/alphastreet.com\/india\/indegene-ltd-indgn-q3-2026-earnings-call-transcript\/","url_meta":{"origin":178484,"position":4},"title":"Indegene Ltd (INDGN) Q3 2026 Earnings Call Transcript","author":"News desk","date":"April 6, 2026","format":false,"excerpt":"Indegene Ltd (NSE: INDGN) Q3 2026 Earnings Call dated Jan. 30, 2026 Corporate Participants: Abhishek Agarwal \u2014 Investor Relations Manish Gupta \u2014 Chairman and Chief Executive Office Suhas Prabhu \u2014 Chief Financial Officer Analysts: Analyst Satish Kumar \u2014 Analyst Chirag Kachhadiya \u2014 Analyst Sucrit Patil \u2014 Analyst Kawaljeet Saluja \u2014\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":142067,"url":"https:\/\/alphastreet.com\/india\/pb-fintech-limited-q3fy23-earnings-story\/","url_meta":{"origin":178484,"position":5},"title":"PB Fintech Limited Q3FY23 Earnings Story","author":"Karan_Singh","date":"February 16, 2023","format":false,"excerpt":"PB Fintech Ltd, also known as Policybazaar, is India\u2019s largest online platform which deals with\u00a0 insurance and lending products through its flagship brands - Paisabazaar and Policybazaar. This is a platform via which they provide convenient access to credit, insurance, and other financial products. Financial Results: PB Fintech Ltd.\u2019s revenue\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"Indegene","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/178484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2378"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=178484"}],"version-history":[{"count":3,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/178484\/revisions"}],"predecessor-version":[{"id":178488,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/178484\/revisions\/178488"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125269"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=178484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=178484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=178484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}